ChemScence
ChemScene manufactures and distributes 80,000+ molecular building blocks, catalysts, life science reagents, and material science products to pharmaceutical, biotechnology, academic, and materials science researchers globally via a five-warehouse e-commerce platform with custom synthesis and CDMO-adjacent services.
- Company typePrivate
- Founded2013
- HeadquartersMonmouth Junction, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What ChemScence does
ChemScene is a privately held U.S.-headquartered chemical supplier that manufactures and distributes molecular building blocks, catalysts and ligands, material science products, life science reagents, and bioactive molecules for pharmaceutical, biotechnology, academic, and materials science researchers. Its catalog includes over 80,000 in-stock building blocks, 10,000+ material science products, 2,200+ life science SKUs, and 4,000+ small molecules in screening libraries, all accessible through a multilingual e-commerce platform supporting structure, CAS number, and chemical name search.
The company operates a vertically integrated model combining catalog distribution, custom synthesis, and an emerging service portfolio covering GMP commercial production, antibody-drug conjugate (ADC) development, peptide custom synthesis, and oligonucleotide drug process services. Screening libraries are designed using AI-driven molecular screening for targets including cysteine proteases, CRBN, and allosteric pockets. Five owned-and-operated warehouses in the U.S., Germany, China, India, and Japan enable door-to-door global delivery, and the storefront is available in six languages.
ChemScene serves a long-tail global customer base of pharma and biotech R&D teams, materials science researchers, and academic institutions, with revenue generated through one-time catalog purchases, bulk ordering, custom synthesis contracts, and screening library subscriptions. Pricing is quote-based and not publicly disclosed, with flexible quantities ranging from milligrams to kilograms. The company has 501-1,000 employees, no disclosed funding rounds or institutional investors, and no public financials.
ChemScence firmographics
Firmographics- Name
- ChemScence
- Legal name
- ChemScene
- Website
- https://chemscene.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- ChemScene manufactures and distributes 80,000+ molecular building blocks, catalysts, life science reagents, and material science products to pharmaceutical, biotechnology, academic, and materials science researchers globally via a five-warehouse e-commerce platform with custom synthesis and CDMO-adjacent services.
- Ownership category
- akta.pro rank
ChemScence industry classification
Industry- Product category
- Pharmaceutical Research Chemicals
- NAICS
- Chemical Manufacturing (325), Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Miscellaneous Chemical Products (2890), Chemicals & Allied Products (2800), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE)
- akta.pro secondary industries
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Catalysts & Adsorbents (IMAEABAB), Display & Optoelectronics Chemicals (OLED/LCD materials, polarizer chemicals) (IMAEAKAN)
Keywords
Where ChemScence is headquartered
LocationHeadquarters
- HQ city
- Monmouth Junction
- HQ country
- United States
- HQ region
- North America
Offices5 records
Markets served
ChemScence business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Inventory, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Product Sales - Building Blocks and Chemical Reagents: Sale of molecular building blocks, catalysts, ligands, and chemical reagents for pharmaceutical R&D. Products are offered in flexible quantities from milligrams to kilograms, with both standard catalog items and custom synthesis options available.
- Custom Synthesis Services: Custom synthesis services including new drug research and development, pharmaceutical intermediates custom synthesis, complex active molecules research and development, chiral compounds customization, and chemical library design and synthesis.
- Specialized Material Products: Sale of specialized materials including MOF&COF materials and ligands, solar cell materials, polymer materials, nanocarbon materials, electronic materials, organic-inorganic hybrid materials, and photonic/optical materials.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
ChemScence product offering
Product offeringCore offering
ChemScence manufactures and supplies molecular building blocks, catalysts and ligands, life science reagents, and material science chemicals for pharmaceutical R&D. The company operates an e-commerce platform with over 80,000 in-stock building blocks and offers custom synthesis, GMP commercial production, ADC, peptide, and oligonucleotide process development services for global drug discovery researchers.
Product overview
ChemScence offers a comprehensive portfolio of pharmaceutical R&D solutions organized into nine core product categories: Building Blocks (80,000+ molecular building blocks), Catalysts and Ligands (photocatalysts, transition metal catalysts, chiral ligands), Material Science (10,000+ materials including MOFs, COFs, solar cell materials), Life Science (2,200+ products including linkers, amino acids, nucleotides, LNP components), General Reagents, Analytical Science, Thin Layer Chromatography, Deuterated Compounds, and Bioactive Molecules. The Bioactive Molecules category includes Screening Libraries featuring specialized compound collections for drug discovery, such as the Lead-like Diversity Library Plus (80,000+ compounds), Cysteine Protease Focused Library (AI-designed), and CNS MPO Lead-like Library. The company also provides complementary service offerings including Custom Synthesis, Commercial/GMP Production, ADC One-Stop Service, Peptide Custom Service, and Oligonucleotide Drug Process Service. Products are available in flexible quantities from milligrams to kilograms with both standard and custom solutions.
Differentiator
Problem solved
Functional benefit
Products and services
- Building Blocks A comprehensive catalog of over 80,000 molecular building blocks used to synthesize complex compounds with specific activities, including functional groups, heterocyclic structures, and chiral compounds for pharmaceutical R&D researchers.
- Catalysts and Ligands Chemical catalysts and ligands including photocatalysts, transition metal catalysts, chiral phosphorus ligands, nitrogen heterocyclic carbene ligands, and organocatalytic small molecules for accelerating reactions and improving selectivity.
- Material Science Products Over 10,000 materials science products including MOF and COF materials, solar cell materials, polymer materials, nanocarbon materials, electronic materials, organic-inorganic hybrid materials, and photonic/optical materials.
- Life Science Products More than 2,200 life science spot products including PEG linkers, ADC linkers, PROTAC linkers, amino acids and derivatives, nucleosides and nucleotides, LNP components, ADC-related compounds, click chemistry reagents, and biochemicals.
- General Reagents General chemical reagents including elements and their salts, oxidants, ionic liquids, reductive reagents, halogenating reagents, condensation reagents, and protection/derivatization reagents essential for organic synthesis.
- Analytical Science Analytical chemistry products including drug impurity reference substances, ion pair chromatography reagents, indicators, and NMR solvents for qualitative and quantitative chemical composition analysis.
- Thin Layer Chromatography Thin layer chromatography products including TLC analysis plates, aluminum TLC plates, TLC preparation plates, TLC adsorbents, and related consumables for compound separation and analysis.
- Deuterated Compounds Deuterated compounds obtained by replacing hydrogen atoms with deuterium atoms, including NMR solvents, molecular building blocks, optoelectronic materials, biochemical reagents, and drug intermediates.
- Bioactive Molecules Bioactive molecules including bioactive small molecules, dye and bio-assay reagents, natural products, peptides, isotope-labeled compounds, and screening libraries for drug discovery and research.
- Screening Libraries Ready-to-use compound libraries featuring over 4,000 small molecules with validated biological and pharmacological activities for high-throughput screening and high-content screening in drug discovery, including specialized focused libraries.
- Custom Synthesis Services Customized synthesis services including new drug research and development, pharmaceutical intermediates custom synthesis, complex active molecules research and development, chiral compounds customization, and chemical library design and synthesis.
- Commercial Production GMP production and commercial manufacturing capabilities for pharmaceutical intermediates and active pharmaceutical ingredients.
- ADC One-Stop Service Comprehensive antibody-drug conjugate (ADC) development service covering linker synthesis, payload development, and ADC conjugation.
- Peptide Custom Service Custom peptide synthesis service for research and pharmaceutical applications.
- Oligonucleotide Drug Process Service Process development and manufacturing service for oligonucleotide-based therapeutics.
Quantifiable outcome
- Over 80,000 building blocks available in stock for immediate delivery
- +3 more outcomes
Companies that use ChemScence
Customer profileSegments3 records
Ideal customer profiles3 records
ChemScence technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature3 records
ChemScence partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
ChemScence competitors and assessment
Company assessmentDirect peers
- TCI Chemicals: TCI is a Japan-headquartered specialty chemical manufacturer and supplier of organic reagents, building blocks, and research chemicals with deep catalog and global distribution. It is one of the most direct competitors to ChemScene's core building blocks and reagents business, with similar product breadth and comparable Asian warehouse footprint.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies antibodies, biochemicals, and chemical reagents for life science research with global distribution. It overlaps with ChemScene's life science reagents, biochemicals, and research reagent offerings, particularly in serving academic and pharma researchers.
- MedChemExpress (MCE): MCE is a leading China-based supplier of building blocks, screening libraries, and bioactive molecules for drug discovery, with global warehouses and a multi-language e-commerce platform. It is among the closest direct competitors to ChemScene, with very similar product mix, screening library offerings, and e-commerce-led GTM motion.
- AstaTech: AstaTech is a U.S.-based supplier of chemical building blocks, intermediates, and custom synthesis services for pharmaceutical and biotech research. It directly competes with ChemScene's core building blocks and custom synthesis offerings with a similar customer base of pharma and academic researchers.
- Enamine: Enamine is a Ukraine-based leading supplier of building blocks, screening compounds, and custom synthesis services, with a catalog of millions of compounds. It overlaps significantly with ChemScene's catalog sales and custom synthesis services for drug discovery, including focused screening libraries and real compound inventory.
- BLD Pharm: BLD Pharm is a China-based supplier of building blocks, intermediates, and custom synthesis services for pharmaceutical R&D with global distribution. It is a close direct competitor to ChemScene with similar product positioning, scale, and e-commerce-led international GTM.
- Combi-Blocks: Combi-Blocks is a U.S.-based supplier of chemical building blocks, fluorinated compounds, and screening libraries focused on drug discovery researchers. It directly competes with ChemScene's building blocks catalog and offers comparable custom synthesis services for pharmaceutical intermediates.
Broad incumbents
- Alfa Aesar (Thermo Fisher Scientific): Alfa Aesar, part of Thermo Fisher Scientific, supplies research chemicals, precious metals, and inorganic/organic reagents with extensive global catalog. It overlaps substantially with ChemScene's building blocks, catalysts, and material science offerings, backed by Thermo Fisher's vast distribution and compliance infrastructure.
- Sigma-Aldrich (MilliporeSigma / Merck KGaA): MilliporeSigma (the life science business of Merck KGaA) is the global leader in chemical building blocks, reagents, and analytical products. It directly overlaps with ChemScene's building blocks, catalysts, and life science offerings but operates at vastly greater scale with a much broader portfolio including Sigma-Aldrich branded catalog and SAFC CDMO services.
Emerging players
- Ambeed: Ambeed is a China-headquartered supplier of building blocks, APIs, and intermediates with growing global presence and warehouse operations. It competes with ChemScene in the mid-market building blocks segment and represents a fast-rising emerging player in the same product category.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
ChemScence social profiles
Digital presenceChemScence financial estimates
Financial estimateRevenue estimate
Valuation estimate
ChemScence leadership team
Management profileNumber of profiles
ChemScence funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ChemScence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ChemScence
What does ChemScence do?
ChemScence manufactures and supplies molecular building blocks, catalysts and ligands, life science reagents, and material science chemicals for pharmaceutical R&D. The company operates an e-commerce platform with over 80,000 in-stock building blocks and offers custom synthesis, GMP commercial production, ADC, peptide, and oligonucleotide process development services for global drug discovery researchers.
Is ChemScence a public or private company?
ChemScence is a private company. It is classified as unknown and is currently operating.
When was ChemScence founded?
ChemScence was founded in 2013. It employs 501 to 1,000 people.
Where is ChemScence based?
ChemScence is headquartered in Monmouth Junction, United States, in the North America region.
How does ChemScence make money?
Three revenue lines are on record. Product Sales - Building Blocks and Chemical Reagents are the primary driver. The others are custom Synthesis Services and specialized Material Products.
Who are ChemScence's main competitors?
Direct peers on record are TCI Chemicals, Santa Cruz Biotechnology, MedChemExpress (MCE), AstaTech, Enamine, BLD Pharm and Combi-Blocks. Broad incumbents are Alfa Aesar (Thermo Fisher Scientific) and Sigma-Aldrich (MilliporeSigma / Merck KGaA). Ambeed is listed as an emerging player.
Does ChemScence have an API?
No public API is recorded for ChemScence.
What industry is ChemScence in?
ChemScence's product category is Pharmaceutical Research Chemicals. Its primary akta.pro industry code is HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services, with a secondary code of HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization. Its NAICS code is 325 and its SIC code is 2890.